Acid Reflux and Peptides: What You Need to Know
If you have started a GLP-1 agonist protocol and noticed heartburn creeping in where it never existed before, you are not imagining it. Acid reflux is one of the most commonly reported gastrointestinal effects of these medications, and for many people it shows up in the first weeks of treatment. Understanding why it happens, when it warrants medical attention, and what you can do about it in your daily routine makes a real difference in how the protocol feels over time.
When food moves more slowly than your body expects, the stomach keeps producing acid even as the door at the top relaxes. That combination is the basic mechanism behind most reflux complaints on GLP-1 agonists. Harvard Health notes that delayed gastric emptying is a well-documented effect of these medications, and the resulting pressure against the lower esophageal sphincter is what causes the burning sensation.
The relationship between dose and symptoms is worth knowing. Reflux tends to appear or intensify during the first few days after an injection, when the medication is approaching its peak action. As the dose increases over weeks, the effect on gastric motility becomes more pronounced, and symptoms can get temporarily worse before the body adjusts. Occasional mild heartburn after a heavier meal while on a GLP-1 agonist is different from persistent reflux that disrupts sleep or requires constant antacid use. One is a common adjustment reaction; the other is a signal that deserves attention.